Insider transaction details
Adam C. Spice, Rocket Lab Corp's chief financial officer, sold 59,714 shares of the company's common stock on March 2, 2026, according to a Securities and Exchange Commission filing. The divestiture was carried out in several tranches at weighted average prices spanning $66.8288 to $70.617, producing total proceeds of approximately $4.3 million.
The sales were broken down as follows: 4,489 shares at an average price of $66.8288; 3,165 shares at $67.9207; 11,528 shares at $69.1034; 36,633 shares at $70.0313; and 6,929 shares at $70.617. The transactions were executed under a pre-arranged sell-to-cover plan implemented pursuant to Rule 10b5-1, and were completed to satisfy tax-withholding requirements arising from the vesting of restricted stock units (RSUs).
Post-transaction holdings and market context
After the sales, Spice directly holds 1,296,824 shares of Rocket Lab. The company’s stock was trading at $71.91 at the time of reporting, representing a 253% gain over the past 12 months. The report notes that InvestingPro’s analysis indicates the shares may be overvalued at current price levels.
Company performance highlights
Separately, Rocket Lab USA reported record fiscal 2025 revenue of approximately $602 million, which exceeded both consensus expectations and the firm's guidance. The company completed 21 successful space launches during the fiscal year, including a quarterly record of seven launches in the fourth quarter.
Operational revenue trends in the fourth quarter included a 29% year-over-year increase in Space Systems revenue and a 38% year-over-year rise in Launch revenue. Fourth-quarter revenue overall was reported as 2% above consensus.
Analyst reactions and revised outlooks
Analysts have responded to the results and program timelines with a mix of adjustments to price targets and ratings. Cantor Fitzgerald raised its price target to $85 and kept an Overweight rating on the shares. Needham trimmed its price target to $95 from $110, citing a delay in the Neutron launch, but maintained a Buy rating in light of the company delivering fourth-quarter revenue above consensus.
Craig-Hallum increased its price target to $68, describing the fourth-quarter performance as largely in line with expectations while warning of possible downward revisions to profitability. KeyBanc retained a Sector Weight rating and pointed to a revised Neutron launch schedule now expected in the fourth quarter of 2026.
Research resources
For investors seeking deeper analysis, a Pro Research Report is available for Rocket Lab and more than 1,400 other U.S. equities, according to the filing.
This report presents the transaction and related company developments as disclosed in regulatory filings and company reports. It does not include additional commentary beyond the facts disclosed in those documents.